Krishna Patel

Dr. Krishna Patel

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in Hospital Pediatrics
Verified
Journal Article
Closed access
PDF file
CCCourtney Cox
Courtney Cox
KPKrishna Patel
Krishna Patel
RCRebecca Cantu
Rebecca Cantu
Chary AkmyradovChary Akmyradov
Chary Akmyradov
KIKatherine Irby
Katherine Irby
Status asthmaticus is commonly treated in pediatric patients by using continuous albuterol, which can cause hypokalemia. The primary aim of this study was to determine if serial potassium monitoring is necessary by examining treatment frequency of hypokalemia. This retrospective analysis was performed in 185 pediatric patients admitted with status asthmaticus requiring continuous albuterol between 2017 and 2019. All patients were placed on intravenous fluids containing potassium. The primary outcome measure was the treatment of hypokalemia in relation to the number of laboratory draws for potassium levels. The secondary outcome measure was hypokalemia frequency and relation to the duration and initial dose of continuous albuterol. Included were 156 patients with 420 laboratory draws (average, 2.7 per patient) for potassium levels. The median lowest potassium level was 3.40 mmol/L (interquartile range, 3.2–3.7). No correlation was found between initial albuterol dose and lowest potassium level (P = .52). Patients with hypokalemia had a mean albuterol time of 12.32 (SD, 15.76) hours, whereas patients without hypokalemia had a mean albuterol time of 11.50 (SD, 12.53) hours (P = .29). Potassium levels were treated 13 separate times. The number of laboratory draws for potassium levels was high in our cohort, with few patients receiving treatment for hypokalemia beyond the potassium routinely added to maintenance fluids. Length of time on albuterol and dose of albuterol were not shown to increase the risk of hypokalemia. Serial laboratory measurements may be decreased to potentially reduce health care costs, pain, and anxiety surrounding needlesticks.

1 August 2025 in American Journal of Public Health
Verified
Journal Article
Closed access
KPKrishna Patel
Krishna Patel
TMTimothy C. McCall
Timothy C. McCall
MCMargaret Cunningham
Margaret Cunningham
CGChloe Garofalini
Chloe Garofalini
JLJoi Lee
Joi Lee
AAAaron A Alford
Aaron A Alford
Objectives. To explore whether and how the local health department (LHD) workforce shifted during the COVID-19 pandemic given the large influx of supplemental funding to public health. Methods. We used data from the National Association of County and City Health Officials National Profile of Local Health Departments, the main source of comprehensive data collected from LHDs across the United States. Total numbers of employees, total numbers of full-time equivalents (FTEs), and employee types (full time, part time, contractual, and seasonal) were used to estimate the total LHD workforce in 2022, changes in the LHD workforce from 2019 to 2022, and changes in the LHD workforce from 2019 to 2022 by employee type. Results. In 2022, the estimated LHD workforce consisted of 182 100 employees or 163 200 FTEs. Between 2019 and 2022, there was a 19% increase in the total LHD workforce, but the size of the workforce varied according to jurisdiction size and rurality. The largest increase was among contract workers (175%), whereas the full-time workforce grew by approximately 7%, indicating that the permanent workforce was predominantly unchanged. Conclusions. With the surge in temporary and contract workers in 2022, there are concerns regarding the sustainability of the LHD workforce. Without continued strategic and sustained funding across jurisdiction types, the workforce may be in jeopardy. ( Am J Public Health. 2025;115(8):1271–1277. https://doi.org/10.2105/AJPH.2025.308096 )

8 January 2024 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
KPKrishna Patel
Krishna Patel
EPEmily Pokorski
Emily Pokorski
DNDonna Norkoli
Donna Norkoli
EDEmily Dunkel
Emily Dunkel
XWXinyue Wang
Xinyue Wang
LYLawrence H. Yang
Lawrence H. Yang
Introduction: Cessation of substance use, a facet of recovery, as well as mitigating stigma experienced by individuals with substance use disorder (SUD), are important to supporting health and well-being of those who use substances. But there is limited and mixed evidence on whether cessation of substance use has a positive impact on individuals’ stigma experiences. This study examined whether there were differences in stigma perceptions between those who self-report using substances and those who self-report not currently using substances associated with their SUD.Materials and methods: A survey was conducted among individuals in 10 counties of Michigan with self-identified history with SUD. The survey aimed to understand five dimensions of stigma perceptions: enacted stigma, anticipated stigma, internalized stigma, social withdrawal, and treatment stigma. Survey items for each measure were adapted from prior literature. The mean was calculated for each stigma measure for analyses. Data analyses tested whether there were significant differences in each of the five stigma domains between the two groups using either regression or t-test, depending on the necessity to include covariates.Results: Findings suggested that among the five stigma domains, only internalized stigma showed statistically significant differences between the two groups (b = 0.19, se = 0.08, p < 0.05) after adjusting for covariates (as needed). Those who were no longer using substances had lower internalized stigma compared to those who were currently using substances associated with their SUD. Analyses suggested that the other four stigma domains, enacted stigma, anticipated stigma, social withdrawal, and treatment stigma, did not show statistically significant differences between the two groups.Discussion: While self-stigmatization (i.e., internalized stigma) was lower among those who report no longer using, our patterns suggest a persistence of stigma regardless of cessation of substances associated with SUD, particularly among stigma domains that are based on perceptions of how others may still perceive individuals who have used substances. Though more research is needed, results suggest that public health programmatic, policy, and campaign efforts that aim to eliminate stigma should account for and tailor to both people who report using and those who report no longer using substances to capture the breadth of needs in communities.

17 July 2025 in Journal of Public Health Management & Practice
Verified
Journal Article
Open access
JJJacquelyn Jacobs
Jacquelyn Jacobs
BSBritney Smart
Britney Smart
MBMaureen Benjamins
Maureen Benjamins
JVJesus Valencia
Jesus Valencia
ACAnna Clayton
Anna Clayton
AEAshley Edmiston
Ashley Edmiston
Context: Local health departments (LHDs) are a critical component of the US public health infrastructure. To guide their work and evaluate progress, LHDs develop and maintain a range of planning documents, including strategic plans (SPs), community health improvement plans (CHIPs), and quality improvement plans (QIPs). Objective: The goal of this study was to provide information on current LHD practices related to strategic planning and performance improvement. Design: The study used an environmental scan and document analysis of a sample of 93 plans from 31 LHDs to explore commonalities and differences within the strategies, goals, and priorities of SPs, CHIPs, and QIPs. Framework analysis was used, involving initial document review, development of a coding framework, and applying this framework to all documents iteratively. To ensure reliability, 19% of documents were double-coded, with discrepancies resolved through team discussions. Results: Of the 31 LHDs included in this analysis, most were urban (89.7%) and medium-sized (64.5%), with a large percentage from the Midwest (41.9%). The analysis revealed that most LHDs used established frameworks to develop plans and identify priority areas. Frequently listed priority areas included behavioral health, social determinants of health, access to care, chronic disease, and nutrition and physical activity. Frequently listed strategies to improve priority areas included building collaborations and partnerships, advocating for policy change, increasing access to services and resources, and increasing awareness of issues. While CHIPs frequently incorporated social determinants of health as part of a guiding framework, QIPs focused on fostering continuous quality improvement. Differences were documented based on jurisdiction size, degree of rurality, and region. Conclusions: The study identified a widespread commitment to develop plans using established frameworks, community engagement, and data-driven decision-making, while also highlighting the diverse needs and capacities of LHDs in addressing public health challenges.

1 July 2026 in Journal of Public Health Management & Practice
Verified
Journal Article
Open access
GDGwen Davis
Gwen Davis
MCMargaret Cunningham
Margaret Cunningham
KPKellie Perkins
Kellie Perkins
KPKrishna Patel
Krishna Patel
TMTimothy C. McCall
Timothy C. McCall
Context: Rural populations face greater barriers to care and worse health outcomes than urban populations. Local health departments (LHDs) serving rural populations may play a key role in bridging the clinical care gap within their communities. Objective: To assess and describe the differences in services provided by rural and urban LHDs, as well as the contextual factors contributing to those differences. Methods: Data from the 2022 National Profile of Local Health Departments was used to estimate the provision of various clinical and population-based services and types of occupations employed, across urban and rural LHDs. Analyses were descriptive in nature but weighted by jurisdiction size to provide nationally representative estimates. Results: Rural LHDs were more likely to provide many clinical services, offering care that is often more limited from other providers in the jurisdiction than urban LHDs. Conversely, fewer rural LHDs tend to provide population-based services or programs related to emergent public health issues, such as substance use. While 88% of rural LHDs reported that clinical substance use care was available through other community organizations, this is less than the proportion of urban LHDs (94%). Fewer rural LHDs also provide population-based primary prevention in this area than urban LHDs. Fewer rural LHDs employ occupations that support the provision of population-based services than urban LHDs. Conclusions: Rural LHDs are a key clinical service provider in their communities. However, they may have challenges prioritizing population-based services and those addressing emergent public health issues. Implications include supporting rural LHDs through formula-based funding, workforce capacity, and partnerships to continue and bolster both clinical and population-based services available for their communities.

30 September 2021
Verified
Conference Paper
Open access
PDF file
KPKrishna Patel
Krishna Patel
JSJemma Shanley
Jemma Shanley
DJDavid James
David James
JLJulian Legg
Julian Legg
Background Wheeze is a common reason for children to present to the Emergency Department (ED). Management is directed by the 2019 British Thoracic Society and Scottish Intercollegiate Guideline Network (BTS/SIGN) 2019 national guideline. However, adherence to the guideline has been shown to be suboptimal. Suboptimal care is a preventable factor which, if addressed, can reduce the incidence of future exacerbations and in turn can potentially reduce ED visits. Objectives The project aimed to (1) assess the current adherence to the guideline within a busy paediatric ED, (2) introduce iterative quality improvement (QI) measures to address areas of poor adherence, and (3) establish the impact of these measures on quality of care. Methods Retrospective data was collected from 75 consecutive patients presenting to the ED at Southampton Children’s Hospital and management analysed against the BTS/SIGN guideline. Multiple QI interventions were then employed with education sessions at the senior team and departmental team teaching, and a newly devised wheeze proforma forming the core of the programme. Subsequently, the care received by 70 consecutive patients was studied to establish the efficacy of the QI programme. Results Initial data collection established that only 14% (3/21) of audited components of the guideline had full adherence. Following the QI programme, 39% (7/18) of non-compliant components showed statistically significant improvements including provision of a Personal Asthma Action Plan (p=0.001), assessment of medication adherence (p= 0.036), discussion of triggers (p<0.001), assessment of parent/carer tobacco dependency status (p<0.001) and assessment of patient tobacco dependency status (p=0.022). Aspects that did not show significant improvement after the QI programme included administration of Beta-2 agonists within an hour (p=1.000), administration of steroids within 2 hours (p=0.753), inhaler technique checks (p=0.282), and the booking of asthma clinic follow ups (p=0.777). Following the QIP introduction, the proforma was utilised in 60% of admissions. In patients where the proforma formed part of the QI strategy, 28% (5/18) of non-compliant components showed statistically significant improvements compared to those patients with no proforma. This included inhaler technique checks (p=0.027), assessment of triggers (p<0.001), assessment of medication adherence (p=0.028), recording of the severity of the exacerbation (p<0.001), and assessment of parent/carer tobacco dependency status (p=0.001). Conclusions The introduction of a focussed QI programme resulted in significant improvements in adherence to the national asthma/wheeze guideline through reinforced education. A bespoke proforma proved an essential part of the programme. The proforma has been updated after feedback received, but at present further PDSA cycles are needed to show sustained change. Several important outcomes were not impacted and will be targeted in future QI cycles.